Long-term results of photodynamic therapy for choroidal neovascularization in Japanese patients with pathologic myopia

American Journal of Ophthalmology

Volumn 151, Issue 1, 2011, Pages

  Hayashi, Kengo ^a   Ohno Matsui, Kyoko ^a   Shimada, Noriaki ^a   Moriyama, Muka ^a   Hayashi, Wakako ^a   Wang, Jiying ^a   Yoshida, Takeshi ^a   Tokoro, Takashi ^a   Mochizuki, Manabu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VERTEPORFIN;

ADULT; ARTICLE; ATROPHY; CASE STUDY; CHORIORETINAL ATROPHY; CONTROLLED STUDY; EYE AXIS LENGTH; FEMALE; FOLLOW UP; HUMAN; INTERVENTION STUDY; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYOPIA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REFRACTION ERROR; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

EID: 78650513586     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2010.06.046     Document Type: Article

References (27)

1. A. Iwase, M. Araie, A. Tomidokoro, T. Yamamoto, H. Shimizu, and Y. Kitazawa Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study Ophthalmology 113 8 2006 1354 1362
2. L. Xu, Y. Wang, Y. Li, T. Cui, J. Li, and J.B. Jonas Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study Ophthalmology 113 7 2006 1134 1141
3. S.Y. Cohen, A. Laroche, Y. Leguen, G. Soubrane, and G.J. Coscas Etiology of choroidal neovascularization in young patients Ophthalmology 103 8 1996 1241 1244
4. K. Ohno-Matsui, T. Yoshida, and S. Futagami Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia Br J Ophthalmol 87 5 2003 570 573
5. T. Yoshida, K. Ohno-Matsui, and K. Yasuzumi Myopic choroidal neovascularization: a 10-year follow-up Ophthalmology 110 7 2003 1297 1305
6. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trialVIP report no. 1 Ophthalmology 108 5 2001 841 852
7. K.J. Blinder, M.S. Blumenkranz, and N.M. Bressler Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trialVIP report no. 3 Ophthalmology 110 4 2003 667 673
8. E. Ergun, H. Heinzl, and M. Stur Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia Am J Ophthalmol 138 3 2004 434 438
9. Y. Ikuno, Y. Nagai, and S. Matsuda Two-year visual results for older Asian women treated with photodynamic therapy or bevacizumab for myopic choroidal neovascularization Am J Ophthalmol 149(1 2010 140 146
10. I. Krebs, S. Binder, U. Stolba, C. Glittenberg, W. Brannath, and A. Goll Choroidal neovascularization in pathologic myopia: three-year results after photodynamic therapy Am J Ophthalmol 140 3 2005 416 425
11. D.S. Lam, W.M. Chan, D.T. Liu, D.S. Fan, W.W. Lai, and K.K. Chong Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up Br J Ophthalmol 88 10 2004 1315 1319
12. A. Pece, V. Isola, M. Vadala, and D. Matranga Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia: long-term study Retina 26 7 2006 746 751
13. A. Pece, M. Vadala, V. Isola, and D. Matranga Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization in pathologic myopia: a long-term follow-up study Am J Ophthalmol 143 3 2007 449 454
14. J.M. Ruiz-Moreno, P. Amat, J.A. Montero, and F. Lugo Photodynamic therapy to treat choroidal neovascularisation in highly myopic patients: 4 years' outcome Br J Ophthalmol 92 6 2008 792 794
15. G. Virgili, M. Varano, and G. Giacomelli Photodynamic therapy for nonsubfoveal choroidal neovascularization in 100 eyes with pathologic myopia Am J Ophthalmol 143 1 2007 77 82
16. W.M. Chan, T.Y. Lai, Y. Tano, D.T. Liu, K.K. Li, and D.S. Lam Photodynamic therapy in macular diseases of asian populations: when East meets West Jpn J Ophthalmol 50 2 2006 161 169
17. W.M. Chan, T.Y. Lai, A.L. Wong, D.T. Liu, and D.S. Lam Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study Br J Ophthalmol 91 2 2007 174 179
18. K. Hayashi, K. Ohno-Matsui, and S. Teramukai Photodynamic therapy with verteporfin for choroidal neovascularization of pathologic myopia in Japanese patients: comparison with nontreated controls Am J Ophthalmol 145 3 2008 518 526
19. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trialsTAP report Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group Arch Ophthalmol 117 10 1999 1329 1345
20. A. Kojima, K. Ohno-Matsui, and S. Teramukai Factors associated with the development of chorioretinal atrophy around choroidal neovascularization in pathologic myopia Graefes Arch Clin Exp Ophthalmol 242 2 2004 114 119
21. K. Ohno-Matsui, M. Moriyama, K. Hayashi, and M. Mochizuki Choroidal vein and artery occlusion following photodynamic therapy in eyes with pathologic myopia Graefes Arch Clin Exp Ophthalmol 244 10 2006 1363 1366
22. U. Schmidt-Erfurth, S. Michels, I. Barbazetto, and H. Laqua Photodynamic effects on choroidal neovascularization and physiological choroid Invest Ophthalmol Vis Sci 43 3 2002 830 841 (Pubitemid 34184504)
23. T. Yoshida, K. Ohno-Matsui, and Y. Ohtake Long-term visual prognosis of choroidal neovascularization in high myopia: a comparison between age groups Ophthalmology 109 4 2002 712 719
24. K. Hayashi, K. Ohno-Matsui, and S. Teramukai Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy Am J Ophthalmol 148 3 2009 396 408
25. C.N. Singh, and D.A. Saperstein Combination treatment with reduced-fluence photodynamic therapy and intravitreal injection of triamcinolone for subfoveal choroidal neovascularization in macular degeneration Retina 28 6 2008 789 793
26. A. Yamashita, F. Shiraga, C. Shiragami, A. Ono, and K. Tenkumo One-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy Am J Ophthalmol 149 3 2010 465471.e1
27. M. Reibaldi, N. Cardascia, and A. Longo Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial Am J Ophthalmol 149 2 2010 307315.e302